Reduction of Immunosuppression as Initial Therapy for Posttransplantation Lymphoproliferative Disorder
Reshef, R., Vardhanabhuti, S., Luskin, M. R., Heitjan, D. F., Hadjiliadis, D., Goral, S., Krok, K. L., Goldberg, L. R., Porter, D. L., Stadtmauer, E. A., Tsai, D. E.
Published in American journal of transplantation (01.02.2011)
Published in American journal of transplantation (01.02.2011)
Get full text
Journal Article
Treatment of PTLD with Rituximab or Chemotherapy
Elstrom, R.L., Andreadis, C., Aqui, N.A., Ahya, V.N., Bloom, R.D., Brozena, S.C., Olthoff, K.M., Schuster, S.J., Nasta, S.D., Stadtmauer, E.A., Tsai, D.E.
Published in American journal of transplantation (01.03.2006)
Published in American journal of transplantation (01.03.2006)
Get full text
Journal Article
Second auto-SCT is safe and effective salvage therapy for relapsed multiple myeloma
OLIN, R. L, VOGL, D. T, STADTMAUER, E. A, PORTER, D. L, LUGER, S. M, SCHUSTER, S. J, TSAI, D. E, SIEGEL, D. L, COOK, R. J, MANGAN, P. A, CUNNINGHAM, K
Published in Bone marrow transplantation (Basingstoke) (01.03.2009)
Published in Bone marrow transplantation (Basingstoke) (01.03.2009)
Get full text
Journal Article
Post-transplant lymphoproliferative disorder: a review
LOREN, A. W, PORTER, D. L, STADTMAUER, E. A, TSAI, D. E
Published in Bone marrow transplantation (Basingstoke) (01.02.2003)
Published in Bone marrow transplantation (Basingstoke) (01.02.2003)
Get full text
Journal Article
EBV PCR in the Diagnosis and Monitoring of Posttransplant Lymphoproliferative Disorder: Results of a Two‐Arm Prospective Trial
Tsai, D. E., Douglas, L., Andreadis, C., Vogl, D. T., Arnoldi, S., Kotloff, R., Svoboda, J., Bloom, R. D., Olthoff, K. M., Brozena, S. C., Schuster, S. J., Stadtmauer, E. A., Robertson, E. S., Wasik, M. A., Ahya, V. N.
Published in American journal of transplantation (01.05.2008)
Published in American journal of transplantation (01.05.2008)
Get full text
Journal Article
The Impact of EBV Status on Characteristics and Outcomes of Posttransplantation Lymphoproliferative Disorder
Luskin, M. R., Heil, D. S., Tan, K. S., Choi, S., Stadtmauer, E. A., Schuster, S. J., Porter, D. L., Vonderheide, R. H., Bagg, A., Heitjan, D. F., Tsai, D. E., Reshef, R.
Published in American journal of transplantation (01.10.2015)
Published in American journal of transplantation (01.10.2015)
Get full text
Journal Article
Gemtuzumab ozogamicin (Mylotarg) monotherapy for relapsed AML after hematopoietic stem cell transplant: efficacy and incidence of hepatic veno-occlusive disease
COHEN, A. D, LUGER, S. M, SICKLES, C, MANGAN, P. A, PORTER, D. L, SCHUSTER, S. J, TSAI, D. E, NASTA, S, GEWIRTZ, A. M, STADTMAUER, E. A
Published in Bone marrow transplantation (Basingstoke) (01.07.2002)
Published in Bone marrow transplantation (Basingstoke) (01.07.2002)
Get full text
Journal Article
Long‐term safety with ≥12 months of pirtobrutinib in relapsed/refractory B‐cell malignancies
Wang, Y., Coombs, C. C., Shah, N. N., Jurczak, W., Woyach, J., Cheah, C. Y., Patel, K., Maddocks, K., Muehlenbein, C. E., Wang, C., Abhyankar, S., Tsai, D. E., Eyre, T. A.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
Removal of gadolinium by peritoneal dialysis
Murashima, M, Drott, H R, Carlow, D, Shaw, L M, Milone, M, Bachman, M, Tsai, D E, Yang, S-L, Bloom, R D
Published in Clinical nephrology (01.05.2008)
Published in Clinical nephrology (01.05.2008)
Get more information
Journal Article
Long-term event-free survivors after high-dose therapy and autologous stem-cell transplantation for low-grade follicular lymphoma
ANDREADIS, C, SCHUSTER, S. J, DOWNS, L. H, MANGAN, P. A, CUNNINGHAM, K. A, HUMMEL, K. A, GIMOTTY, P. A, SIEGEL, D. L, GLATSTEIN, E, STADTMAUER, E. A, CHONG, E. A, SVOBODA, J, LUGER, S. M, PORTER, D. L, TSAI, D. E, NASTA, S. D, ELSTROM, R. L, GOLDSTEIN, S. C
Published in Bone marrow transplantation (Basingstoke) (01.12.2005)
Published in Bone marrow transplantation (Basingstoke) (01.12.2005)
Get full text
Journal Article
PIRTOBRUTINIB IN COVALENT BTK‐INHIBITOR PRE‐TREATED MANTLE CELL LYMPHOMA: UPDATED RESULTS, SUBGROUP ANALYSIS FROM BRUIN WITH >3 YEARS FOLLOW‐UP FROM START OF ENROLLMENT
Cheah, C. Y., Shah, N. N., Jurczak, W., Zinzani, P. Luigi, Eyre, T. A., Ujjani, C. S., Izutsu, K., Ma, S., Flinn, I., Alencar, A. J., Lewis, D., Patel, K., Maddocks, K., Wang, Y., Munir, T., Zelenetz, A. D., Balbas, M., Tsai, D. E., Wang, C., Wang, M. L.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
Intensive graft-versus-host disease prophylaxis is required after unrelated-donor nonmyeloablative stem cell transplantation
LOREN, A. W, LUGER, S. M, GREEN, J, EMERSON, S. G, PORTER, D. L, STADTMAUER, E. A, TSAI, D. E, SCHUSTER, S, NASTA, S. D, GOLDSTEIN, S. C, PERL, A, ORLOFF, G, OLIVER, J. C
Published in Bone marrow transplantation (Basingstoke) (01.05.2005)
Published in Bone marrow transplantation (Basingstoke) (01.05.2005)
Get full text
Journal Article
PIRTOBRUTINIB (LOXO‐305), A NEXT GENERATION HIGHLY SELECTIVE NON‐COVALENT BTK INHIBITOR IN PREVIOUSLY TREATED RICHTER TRANSFORMATION: RESULTS FROM THE PHASE 1/2 BRUIN STUDY
Jurczak, W., Shah, N. N., Lamanna, N., Eyre, T. A., Woyach, J., Lech‐Maranda, E., Wierda, W. G., Lewis, D., Thompson, M. C., Wang, D., Yin, M., Balbas, M., Nair, B. C., Zhu, E. Y., Tsai, D. E., Ku, N. C., Coombs, C. C., Mato, A. R.
Published in Hematological oncology (01.06.2021)
Published in Hematological oncology (01.06.2021)
Get full text
Journal Article
P640: PIRTOBRUTINIB, A HIGHLY SELECTIVE, NON‐COVALENT (REVERSIBLE) BTK INHIBITOR IN COMBINATION WITH VENETOCLAX±RITUXIMAB IN RELAPSED/REFRACTORY CLL: RESULTS FROM THE BRUIN PHASE 1B STUDY
Roeker, L. E., Mato, A. R., Brown, J. R., Coombs, C. C., Shah, N. N., Wierda, W. G., Patel, M. R., Lewis, K. L., Balbas, M., Zhao, J., Ku, N. C., Kherani, J. F., Tsai, D. E., Nair, B., Cheah, C. Y.
Published in HemaSphere (01.06.2022)
Published in HemaSphere (01.06.2022)
Get full text
Journal Article
Rituximab (anti-CD20 monoclonal antibody) therapy for progressive intermediate-grade non-Hodgkin's lymphoma after high-dose therapy and autologous peripheral stem cell transplantation
TSAI, D. E, MOORE, H. C. F, HARDY, C. L, PORTER, D. L, LOH, E. Y, VAUGHN, D. J, LUGER, S, SCHUSTER, S. J, STADTMAUER, E. A
Published in Bone marrow transplantation (Basingstoke) (01.09.1999)
Published in Bone marrow transplantation (Basingstoke) (01.09.1999)
Get full text
Journal Article
P1101: PIRTOBRUTINIB, A HIGHLY SELECTIVE, NON‐COVALENT (REVERSIBLE) BTK INHIBITOR IN PREVIOUSLY TREATED MANTLE CELL LYMPHOMA: UPDATED RESULTS FROM THE PHASE 1/2 BRUIN STUDY
Eyre, T. A., Wang, M. L., Shah, N. N., Alencar, A. J., Gerson, J. N., Patel, M. R., Fakhri, B., Vandenberghe, E., Jurczak, W., Tan, X. N., Lewis, K. L., Fenske, T., Wang, Y., Coombs, C. C., Flinn, I., Lewis, D., Le Gouill, S., Gandhi, M., Chay, C., Palomba, M. L., Woyach, J. A., Pagel, J. M., Lamanna, N., Sharman, J. P., Andorsky, D. J., Cohen, J. B., Barve, M. A., Ghia, P., Yin, M., Zinzani, P. L., Ujjani, C., Koh, Y., Izutsu, K., Lech‐Maranda, E., Kherani, J., Tam, C., Sundaram, S., Nair, B., Tsai, D. E., Balbas, M., Mato, A. R., Cheah, C. Y.
Published in HemaSphere (23.06.2022)
Published in HemaSphere (23.06.2022)
Get full text
Journal Article
S147: PIRTOBRUTINIB, A HIGHLY SELECTIVE, NON‐COVALENT (REVERSIBLE) BTK INHIBITOR IN PREVIOUSLY TREATED CLL/SLL: UPDATED RESULTS FROM THE PHASE 1/2 BRUIN STUDY
Mato, A. R., Pagel, J. M., Coombs, C. C., Shah, N. N., Lamanna, N., Munir, T., Lech‐Maranda, E., Eyre, T. A., Woyach, J. A., Wierda, W. G., Cheah, C. Y., Cohen, J. B., Roeker, L. E., Patel, M. R., Fakhri, B., Barve, M. A., Tam, C., Lewis, D., Gerson, J. N., Alencar, A. J., Ujjani, C., Flinn, I., Sundaram, S., Ma, S., Jagadeesh, D., Rhodes, J., Taylor, J., Abdel‐Wahab, O., Ghia, P., Schuster, S. J., Wang, D., Nair, B., Zhu, E., Tsai, D. E., Davids, M. S., Brown, J. R., Jurczak, W.
Published in HemaSphere (01.06.2022)
Published in HemaSphere (01.06.2022)
Get full text
Journal Article
COMPARISON OF BLEEDING-RELATED EVENTS IN PATIENTS WHO RECEIVED PIRTOBRUTINIB WITH AND WITHOUT ANTITHROMBOTIC AGENTS
Lamanna, N, Tam, CS, Jurczak, W, Kontos, A, Konig, H, Ruppert, AS, Tsai, DE, Scheliga, AAS
Published in Hematology, Transfusion and Cell Therapy (01.10.2023)
Published in Hematology, Transfusion and Cell Therapy (01.10.2023)
Get full text
Journal Article